US 11084856
Interleukin-4 receptor-binding fusion proteins and uses thereof
granted A61KA61K38/00A61K38/1761
Quick answer
US patent 11084856 (Interleukin-4 receptor-binding fusion proteins and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K38/00, A61K38/1761, A61K38/193, A61K38/2026